Shares of Global Health were trading with a jump of 1.36 percent at Rs 1,409.30 in Wednesday's session, driven by high volume. The stock's performance is noteworthy in the context of current trading dynamics, which have seen a significant surge in volume.
On Wednesday at 1:54 pm, Global Health witnessed high trading activity, which is a notable shift from its recent trading patterns. This level of trading activity suggests increased investor interest in the stock, with the stock being a constituent of the Nifty Midcap 150 index.
Financial Overview:
The financial performance of Global Health reveals a pattern of consistent growth. Consolidated yearly revenue has risen steadily, with figures of Rs 3,692.32 Crore in 2025, up from Rs 3,275.11 Crore in 2024, Rs 2,694.25 Crore in 2023 and Rs 2,166.59 Crore in 2022. Net profit has also increased, from Rs 196.20 Crore in 2022 to Rs 481.32 Crore in 2025. The Earnings Per Share (EPS) reflect this growth, moving from Rs 7.78 in 2022 to Rs 17.92 in 2025.
The company has also demonstrated robust quarterly performance. The revenue for the quarter-ending June 2025 stood at Rs 1,030.84 Crore, up from Rs 861.08 Crore in June 2024. Net profit for the same period increased from Rs 106.26 Crore to Rs 158.98 Crore, and EPS rose from Rs 3.96 to Rs 5.92.
Key financial metrics are detailed in the tables below:
| Consolidated Yearly | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | Rs 2,166.59 Crore | Rs 2,694.25 Crore | Rs 3,275.11 Crore | Rs 3,692.32 Crore |
| Net Profit | Rs 196.20 Crore | Rs 326.08 Crore | Rs 478.06 Crore | Rs 481.32 Crore |
| EPS | Rs 7.78 | Rs 12.58 | Rs 17.80 | Rs 17.92 |
| Consolidated Quarterly | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 861.08 Crore | Rs 956.56 Crore | Rs 943.44 Crore | Rs 931.25 Crore | Rs 1,030.84 Crore |
| Net Profit | Rs 106.26 Crore | Rs 130.82 Crore | Rs 142.86 Crore | Rs 101.38 Crore | Rs 158.98 Crore |
| EPS | Rs 3.96 | Rs 4.87 | Rs 5.32 | Rs 3.77 | Rs 5.92 |
The standalone yearly income statement shows sales of Rs 3,204 Crore for March 2025, compared to Rs 2,280 Crore for March 2024 and Rs 1,959 Crore for March 2023. The net profit was Rs 461 Crore, compared to Rs 360 Crore and Rs 263 Crore for the years March 2024 and March 2023 respectively. The quarterly standalone income statement shows sales of Rs 882 Crore for June 2025, compared to Rs 611 Crore for June 2024. The net profit was Rs 151 Crore, compared to Rs 96 Crore.
Corporate Actions:
Global Health announced the commencement of operations at its Noida Hospital effective from September 1, 2025. Additionally, an analyst/investor meet was conducted, and a post dispatch advertisement for the Annual General Meeting for the FY 2024-25 was published.
Global Health announced a final dividend of Rs 0.50 per share (25%) with an effective date of August 22, 2025. The announcement was made on May 15, 2025.
With the stock's last traded price at Rs 1,409.30, Global Health has seen a positive move, driven by high trading volumes and strong financial performance.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
